✦ LIBER ✦

P1108 EFFICACY AND TOLERABILITY OF TELAPREVIR-BASED TRIPLE THERAPY FOR ADVANCED FIBROSIS STAGE CHRONIC HEPATITIS C PATIENTS: RESULTS OF THE KYUSHU UNIVERSITY LIVER DISEASE STUDY GROUP

✍ Scribed by Furusyo, N.; Ogawa, E.; Nakamuta, M.; Kajiwara, E.; Nomura, H.; Dohmen, K.; Takahashi, K.; Satoh, T.; Azuma, K.; Kawano, A.; Tanabe, Y.; Kotoh, K.; Shimoda, S.; Hayashi, J.

Book ID: 122888717
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 59 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61268-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the adverse effect of prem

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

✍ Eiichi Ogawa; Norihiro Furusyo; Eiji Kajiwara; Kazuhiro Takahashi; Hideyuki Nomu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

Association between the treatment length

Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

✍ Norihiro Furusyo; Eiji Kajiwara; Kazuhiro Takahashi; Hideyuki Nomura; Yuichi Tan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB